Financial Highlights

Financial Highlights
2019 FQ2 YTD
6/30/2019
2018 FY
12/31/2018
2017 FY
12/31/2017
2016 FY
12/31/2016
2015 FY
12/31/2015
Balance Sheet ($000)
Cash and Cash Equivalents 5,627 5,676 6,644 7,368 6,763
Investments 120,547 112,690 114,731 112,657 112,557
Total Assets 151,858 144,231 146,438 148,579 147,841
Total Policy Reserves 79,432 77,988 76,674 76,174 77,043
Total Liabilities 100,805 98,365 98,813 100,527 102,958
Total Mezzanine Level Items 0 0 0 0 0
Equity Attributable to Parent Company 51,053 45,866 47,625 48,052 44,883
Total Equity 51,053 45,866 47,625 48,052 44,883
Equity before Unrealized Gains 48,952 47,251 44,499 46,366 43,423
Total Equity/ Total Assets(%) 33.62 31.80 32.52 32.34 30.36
Reserves/ Equity(x) 1.56 1.70 1.61 1.59 1.72
Income Statement ($000)
Total Policy Income 29,708 60,856 61,163 61,398 59,462
Net Investment Income 2,071 3,277 3,649 4,059 3,429
Realized Gain on Securities 2,085 112 232 831 536
Asset Management and Brokerage Fees 0 0 0 0 0
Total Revenue 34,156 64,857 65,640 66,893 64,050
Total Policy Expense 19,923 40,409 42,869 38,847 34,148
Underwriting & Other Expense 11,864 22,148 22,578 22,600 22,163
Total Expense 32,373 63,792 66,754 62,799 57,703
Net Income 1,856 779 (1,203) 3,063 4,697
Net Income Attributable to Parent 1,856 779 (1,203) 3,063 4,697
Operating Income after Taxes 89 920 (1,355) 2,414 4,370
EBITDA 2,512 2,612 707 5,749 8,038
Per Share Information ($)
Basic Book Value per Share 20.17 18.15 18.88 19.09 17.86
Book Value per Share before Unrealized Gains 19.34 18.70 17.64 18.42 17.28
Diluted EPS after Extraordinary 0.73 0.31 (0.48) 1.22 1.87
EBITDA/ Share 0.99 1.04 0.28 2.29 3.20
Operating EPS 0.04 0.36 (0.54) 0.96 1.74
Price/ LTM Operating Earnings(x) NM 36.10 NM 18.50 8.80
Common Dividends Declared per Share 0.10 0.20 0.20 0.18 0.16
Dividend Payout Ratio(%) 13.70 64.52 NM 14.75 8.56
EPS after Extra Growth(%) 97.30 NM NM (34.80) (38.50)
Profitability (%)
ROAA 2.49 0.53 (0.81) 2.03 3.19
Operating ROAA 0.12 0.63 (0.91) 1.60 2.97
ROAE 7.54 1.67 (2.53) 6.36 10.64
ROATCE 7.54 1.67 (2.53) 6.36 10.64
Operating ROAE 0.36 1.97 (2.85) 5.01 9.90
Investment Yield 6.75 2.82 3.21 3.99 3.36
Combined Ratio 103.80 102.43 102.25 94.59 89.95
P&C Stat Combined Ratio after Dividends NA NA NA NA NA
Reported Medical Care Ratio NA NA NA NA NA
Net Premiums Written/ Avg Equity(x) 1.30 1.30 1.29 1.28 1.37
Growth Rates and Trends (%)
Asset Growth 10.58 (1.51) (1.44) 0.50 2.05
Equity Growth 22.62 (3.69) (0.89) 7.06 4.97
Net Written Premium Growth (0.97) (1.09) (0.22) 1.88 3.75
Recurring Revenue Growth 6.47 (1.19) (1.87) 4.44 4.77
Net Income Growth 100 NM NM (34.79) (38.33)
Assets Five-year CAGR 1.17 1.48 1.53 2.25 1.55
Equity Five-year CAGR 5.88 6.50 9.51 4.79 0.53
Revenue Five-year CAGR 1.21 1.18 1.98 1.50 (1.59)
Net Income Five-year CAGR (8.74) (32.72) NM NM 7.54
Miscellaneous ($000)
Net Premiums Written 31,948 60,717 61,388 61,525 60,389
Gross Life Insurance in Force NA 203,209 206,826 208,420 208,172
Total Membership(actual) 0 0 0 0 0
Assets Under Management 0 0 0 0 0
Data shown on this page is extracted directly from the company’s documents. S&P makes every effort to line up fields, captions and headers that represent the same data over time, despite variations in how the company may report these items in different documents. In certain instances the variation in the company’s presentation over time may be too significant, potentially resulting in repeating and/or disordered items. Despite possible issues with the presentation, S&P, as always, stands by its commitment to the quality of the data.
Copyright 2019, © S&P Global Market Intelligence  Terms of Use